Suchergebnisse - "Pregnenediones"

PubPharm (444)

1

Fabrication and In-Vivo Evaluation of Polyvinyl pyrrolidone/Poloxamer 188 Hybrid Nanofibers of Deflazacort

enthalten in: International journal of pharmaceutics | 2024

von Abdelkader, D. | Belal, A. | Elkordy, E. | +2

2

Comparison of pharmaceutical properties and biological activities of prednisolone, deflazacort, and vamorolone in DMD disease models

enthalten in: Human molecular genetics | 2024

von Liu, G. | Lipari, P. | Mollin, A. | +21

3

Etanercept treatment for pediatric toxic epidermal necrolysis induced by deflazacort : a case report and literature review

enthalten in: Frontiers in immunology | 2024

von Jeong, M. | Choi, Y. | Ahn, Y. | +3

4

Delandistrogene moxeparvovec (Elevidys) for Duchenne muscular dystrophy

enthalten in: The Medical letter on drugs and therapeutics | 2023

5

Is Medical Therapy for Distal Ureteral Stones Efficient? Tamsulosin versus Deflazacort : A Prospective Randomised Trial

enthalten in: Aktuelle Urologie | 2022

von Kucukpolat, S. | Kocaaslan, R. | Kadihasanoglu, M. | +3

6

Prednisone and deflazacort in Duchenne muscular dystrophy : a patient perspective and plain language summary publication of the Cincinnati study

enthalten in: Journal of comparative effectiveness research | 2022

von Wong, B. | Cook, T. | Miller, H.

CommentOn: J Comp Eff Res. 2020 Feb;9(3):177-189. - PMID 31922454

7

Deflazacort dose optimization and safety evaluation in Duchenne muscular dystrophy (DOSE) : A randomized, double-blind non-inferiority trial

enthalten in: European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society | 2022

von Reddy, C. | Patil, A. | Suthar, R. | +7

8

Comparing Deflazacort and Prednisone in Duchenne Muscular Dystrophy

enthalten in: Journal of neuromuscular diseases | 2022

von Biggar, W. | Skalsky, A. | McDonald, C.

9

Meta-analyses of deflazacort versus prednisone/prednisolone in patients with nonsense mutation Duchenne muscular dystrophy

enthalten in: Journal of comparative effectiveness research | 2021

von Shieh, P. | Elfring, G. | Trifillis, P. | +111

10

In vitro cytochrome P450- and transporter-mediated drug interaction potential of 6β-hydroxy-21-desacetyl deflazacort-A major human metabolite of deflazacort

enthalten in: Pharmacology research & perspectives | 2021

von Ma, J. | Beers, B. | Manohar, R. | +3

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[45]